MÖLNDAL, Sweden--(BUSINESS WIRE)--Regulatory News:
Arcam (STO:ARCM), listed on NASDAQ Stockholm, and leading supplier of Additive Manufacturing solutions, announces that its high quality metal powder manufacturing subsidiary, AP&C, based in Montreal, Canada, has filed a strategic patent application that covers high-yield production of fine powder from reactive metals with a low gas to metal ratio and low gas pressure.
AP&C uses proprietary technology for Plasma Atomization. The strategic patent application covers the use of Plasma Atomization on different heated metal sources such as wire, rod and melt. AP&C’s technology allows high yield production of fine powder for all Additive Manufacturing distributions and without ceramic contamination risk.
“The production yield is one of the key drivers to produce powder at low cost. The combination of high-yield of fine powder with a low gas to metal ratio of about 10 is unique to AP&C’s proprietary Plasma Atomization process”, says Jacques Mallette, President of AP&C.
With 10 years+ of experience, AP&C produces high quality and cost effective titanium and nickel super alloy powders for additive manufacturing on a multi-reactor platform using product dedicated equipment.
Arcam Group provides cost-efficient Additive Manufacturing solutions for production of metal components. Arcam’s Electron Beam Melting (EBM®) technology offers design freedom combined with excellent material properties and high productivity. Arcam is, through its solution orientation and comprehensive product offering, an innovative partner for advanced manufacturing, primarily for the aerospace and medical industries. Arcam offers EBM systems through Arcam AB in Sweden, powder metals through AP&C in Canada and implant contract manufacturing through DiSanto in the U.S.The company is listed on Nasdaq Stockholm and the Head Office is located in Mölndal, Sweden.
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com
This information was brought to you by Cision http://news.cision.com